## Abstract Three courses of intensive consolidation therapy were administered to 13 patients with acute leukemia after they achieved complete remission. The patients were randomly allocated to receive their therapy in or out of a protected environment unit and with or without antibiotic prophylaxi
β¦ LIBER β¦
Intensive post-remission consolidation chemotherapy for acute myeloid leukemia (AML) in adults
β Scribed by C. Bernasconi; M. Lazzarino; E. Morra; A. Canevari; G. Castelli; E. Brusamolino; E.P. Alessandrino; G. Pagnucco; E. Orlandi; D. Inverardi; C. Castagnola
- Book ID
- 113238653
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 99 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Early consolidation chemotherapy for adu
β
Bodey, Gerald P. ;Rodriguez, Victorio ;McCredie, Kenneth B. ;Freireich, Emil J.
π
Article
π
1976
π
John Wiley and Sons
π
English
β 567 KB
Autologous Stem Cell Transplant (ASCT) A
β
Cerny, Jan; Ramanathan, Muthalagu; Evens, Andrew; Walsh, William; Rosmarin, Alan
π
Article
π
2013
π
Elsevier Science
π
English
β 136 KB
Chemotherapy for patients with acute mye
β
Kenneth Bradstock
π
Article
π
2006
π
Current Science Inc.
π
English
β 101 KB
Post induction treatment alternatives in
β
Th. BΓΌchner; D. Urbanitz; R. Kuse; G. Maschmeyer; H. RΓΌhl; M. R. Nowrousian; W.
π
Article
π
1986
π
Springer-Verlag
π
English
β 128 KB
Phase I trial of gemtuzumab ozogamicin i
β
Noriko Usui; Akihiro Takeshita; Chiaki Nakaseko; Nobuaki Dobashi; Hiroyuki Fujit
π
Article
π
2011
π
John Wiley and Sons
π
English
β 281 KB
Intensive timed sequential remission ind
β
Loeb, David M. ;Bowers, Daniel C. ;Civin, Curt I. ;Friedman, Alan D.
π
Article
π
2001
π
John Wiley and Sons
π
English
β 91 KB
## Background: Timed sequential chemotherapy and high-dose cytarabine (cytosine arabinoside, ara-c; hdac) are both effective treatments for acute myeloid leukemia (aml). we review our institutional experience with timed sequential induction chemotherapy consisting of daunorubicin/ara-c/-thioguanine